Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer in Combination with An Aromatase Inhibitor as Initial Endocrine-based Therapy in Women

A selection of medicines used for Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer in Combination with An Aromatase Inhibitor as Initial Endocrine-based Therapy in Women is listed below, including Ribociclib. Products containing Ribociclib feature in this group. Prices and product details are shown for comparison.